Wisconsin Hemp Retailers Warn Federal Restrictions Could Force Closures

Federal Action Targets Intoxicating Hemp Derivatives

Federal regulators are moving to restrict the sale of intoxicating hemp-derived cannabinoids including delta-8 THC, delta-10 THC, and THCA, products that currently occupy legal gray areas under the 2018 Farm Bill. The restrictions would close what industry participants call the "hemp loophole" — the interpretation of the Farm Bill's 0.3% delta-9 THC limit that allowed manufacturers to produce psychoactive cannabinoids from hemp.

Under a strict reading of the proposed restrictions, any hemp-derived product designed to produce intoxication would fall outside the Farm Bill's safe harbor. That interpretation conflicts with current market reality. Thousands of retailers nationwide sell delta-8 gummies, THCA flower, and similar products as legal hemp derivatives.

Wisconsin retailers told WEAU the regulatory shift would eliminate between 40% and 70% of their current product lines. Most small-format hemp shops lack the capital or licensing infrastructure to pivot to state-regulated cannabis programs.

Wisconsin's Regulatory Gap Amplifies Impact

Wisconsin hasn't legalized adult-use cannabis, leaving hemp-derived products as the only legal pathway to psychoactive cannabinoids for most consumers. The state's CBD and hemp retail sector grew rapidly after the 2018 Farm Bill, with hundreds of small retailers opening storefronts in the past four years.

State law doesn't provide a regulatory framework for intoxicating hemp products. Wisconsin retailers have operated under federal guidance alone, creating exposure when federal policy shifts. The absence of a state licensing regime means Wisconsin hemp businesses can't easily transition to a regulated cannabis model if federal hemp rules tighten.

Neighboring states including Michigan and Illinois offer adult-use cannabis programs. But Wisconsin retailers can't legally pivot to those markets without relocating their operations.

Economic Stakes for Small Retailers

Local hemp retailers reported annual revenues between $150,000 and $800,000, with intoxicating products accounting for the majority of sales. Owners told WEAU that CBD-only product lines generate insufficient margin to cover rent, payroll, and inventory costs in most retail formats.

The delta-8 and THCA product categories carry higher margins than non-intoxicating CBD oils and topicals. Removing those SKUs would cut gross revenue by half or more, making most locations unprofitable, retailers said. Small operators lack the balance-sheet strength to absorb a prolonged transition period.

One retailer estimated that complying with new federal restrictions would require liquidating $60,000 in current inventory at a loss, then rebuilding a product mix with lower-margin CBD items. The math doesn't work. Businesses operating on thin margins can't sustain that kind of hit.

Compliance Timeline Remains Unclear

Federal agencies haven't published a final rule or enforcement timeline for the new hemp restrictions, leaving retailers in regulatory limbo. The Drug Enforcement Administration and the Food and Drug Administration have both signaled increased scrutiny of intoxicating hemp products, but neither has issued a binding compliance deadline.

Industry attorneys expect a notice-and-comment rulemaking process that could take six to eighteen months. The DEA retains authority to issue interim final rules or enforcement actions on shorter timelines if it determines that intoxicating hemp products pose an imminent public-health risk, however.

Wisconsin retailers told WEAU they're holding existing inventory but have stopped placing new orders for delta-8 and THCA products until the regulatory picture clarifies. That cautious posture creates immediate cash-flow pressure for businesses with high fixed costs.

Industry Groups Push for Legislative Clarity

National hemp trade associations are lobbying Congress to amend the Farm Bill and establish clear standards for intoxicating cannabinoids derived from hemp. The U.S. Hemp Roundtable and the Hemp Industries Association have both called for a regulatory framework that distinguishes between CBD wellness products and psychoactive hemp derivatives.

Legislative proposals under discussion would create a tiered system: non-intoxicating hemp products under USDA oversight, and intoxicating hemp products subject to state-level licensing similar to alcohol or adult-use cannabis. That model would require Wisconsin to pass enabling legislation, a political lift in a state that hasn't advanced adult-use legalization.

For full background on this story, see the CannIntel topic hub on Federal Hemp Restrictions. Without federal or state action, Wisconsin's hemp retailers face a binary choice: exit the intoxicating-product market or risk enforcement.